Visual Podcast: Applying Risk Concepts To Supply Chains And Product Lines Can Be A Snap, Expert Says
This article was originally published in The Gray Sheet
In this Gray Sheet educational podcast, Xavier Health's Marla Phillips explains how a Xavier University initiative uncovered major paradigm shifts that enable industry to apply risk concepts to supply chains and product lines via an approach that promises immediate impact. "We need greater assurance that suppliers can reliably and consistency supply [reliable, safe, quality] materials and products to limit adverse impact on end-user safety and brand equity," she says.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.